For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Biosimilars Chromatography Characterization Guide
Discover how Biozen columns aid in analyzing infliximab and biosimilars through: Primary Structure, Higher Order Structure and Post-translational Modifications.
Biosimilars Chromatography Characterization Guide
Discover how Biozen columns aid in analyzing infliximab and biosimilars through: Primary Structure, Higher Order Structure and Post-translational Modifications.
Document Type:
Guide
Target Industries:
Biopharmaceutical Analysis, Pharmaceutical
Techniques:
HPLC, HPLC-Ion-Exchange, HPLC-SEC, Solid Phase Extraction
Brands:
Biozen LC, Biozen SPE
Separation Modes:
Ion-Exchange, Reversed Phase, Size Exclusion, Solid Phase Extraction
Phases:
Aeris Peptide XB-C18, Aeris Widepore C4, Biozen-Glycan, Biozen-Intact-XB-C8, Biozen MagBeads, Biozen N-Glycan Clean-Up, Biozen-Peptide-PS-C18, Biozen-Peptide-XB-C18, Biozen-SEC-2, Biozen-SEC-3, Biozen WCX, Biozen WidePore C4
save_alt Download
favorite_border
Phenomenex logo
Headquarters
411 Madrid Avenue, Torrance, CA 90501
t: (310) 212-0555 f: (310) 328-7768

OUR PRODUCTS AND SERVICES

Products

Techniques

Industries

OUR COMPANY 

About Phenomenex

Our Humanity

Our People

Blog

Danaher Life Sciences

Stay up to date on the latest from Phenomenex
Iso logo
Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Cookie Settings © 2023 Phenomenex Inc. All rights reserved.